The Anti-Proliferative Activity of Coordination Compound-Based ZnO Nanoparticles as a Promising Agent Against Triple Negative Breast Cancer Cells
Author:
Publisher
Informa UK Limited
Subject
Organic Chemistry,Drug Discovery,General Medicine,Biomaterials,Bioengineering,Biophysics,Pharmaceutical Science
Reference78 articles.
1. A review of nanotechnology-based approaches for breast cancer and triple-negative breast cancer
2. Synthetic cannabinoids nano-micelles for the management of triple negative breast cancer
3. How many diseases is triple negative breast cancer: the protagonism of the immune microenvironment
4. Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery
5. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Anti-proliferative activity of biosynthesized zinc oxide nanoparticles against breast cancer MCF-7 cells;Materials Chemistry and Physics;2024-03
2. Invitro- invivo evaluations of green synthesized zinc oxide (ZnO) nanoparticles using Ipomoea aquatica leaf extract as matric and fillers;Journal of the Mechanical Behavior of Biomedical Materials;2024-02
3. Anticancer activity of zinc oxide nanoparticles on prostate and colon cancer cell line;Toxicology Research;2024-01-01
4. An updated landscape on nanotechnology-based drug delivery, immunotherapy, vaccinations, imaging, and biomarker detections for cancers: recent trends and future directions with clinical success;Discover Nano;2023-12-19
5. Zinc Oxide Nanoparticles (ZnO NPs) Treated Two Types of Osteosarcoma Cell Lines for Identifying Differentially Expressed Genes;Journal of Biomedical Nanotechnology;2023-12-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3